Introduction

Starting April 1, 2026, China will enforce Class III medical device regulations for radiofrequency (RF) beauty devices, requiring mandatory NMPA certification for production, import, and sales. Currently, only 12 products have obtained approval, leaving over 90% of existing models non-compliant. This policy significantly impacts international importers, particularly from Europe, the Middle East, and Southeast Asia, as non-certified products will face customs rejection or market penalties. The beauty device industry, supply chain stakeholders, and regulatory compliance professionals should closely monitor these changes.

Event Overview

As of April 1, 2026, China's National Medical Products Administration (NMPA) will classify RF treatment devices and RF skin treatment devices as Class III medical devices. Only products with official NMPA certification will be permitted for production, import, or sale. Public records indicate that just 12 models have been approved so far, meaning the majority of currently available devices will be phased out. Non-compliant imports may be rejected at customs or subject to regulatory penalties.

Impact on Sub-Industries

International Importers & Distributors

Importers from regions like Europe, the U.S., and the Middle East must verify NMPA certification before shipping. Products lacking approval will face customs clearance delays or forced returns, disrupting inventory and sales channels.

E-Commerce & Retail Platforms

Online and offline sellers must ensure all RF beauty devices in stock carry valid Class III certification. Unauthorized listings risk penalties, including product seizures or fines.

Manufacturers & OEMs

Brands producing RF devices for the Chinese market must expedite NMPA registration. The lengthy approval process (often 12-18 months) could bottleneck new product launches.

Key Action Points for Businesses

1. Verify Certification Status Immediately

Importers should cross-check model numbers against the NMPA’s published list of approved devices. Customs declarations now require registration certificate numbers.

2. Adjust Inventory Strategies

Distributors with non-compliant stock may explore alternative markets or negotiate returns with suppliers before the deadline.

3. Monitor Regulatory Updates

NMPA may release additional guidance on transitional arrangements. Companies should track announcements via official channels like the NMPA website or authorized agents.

Industry Observations

Analysis suggests this policy reflects China’s tightening control over aesthetic medical devices, aligning RF treatments with high-risk categories like surgical lasers. While the immediate effect is market contraction, the move could standardize product safety and performance long-term. Notably, the limited number of approved devices indicates stringent technical reviews—brands should anticipate rigorous testing for future submissions.

Conclusion

The 2026 mandate marks a definitive shift in China’s RF beauty device landscape, prioritizing regulatory compliance over market accessibility. Businesses should treat this as an operational pivot point, focusing on certified suppliers or exploring alternative technologies. Proactive adaptation will be critical to maintaining market access.

Source

National Medical Products Administration (NMPA) official announcement, accessed via [NMPA website URL]. Ongoing updates to the approved devices list are expected.